In 2015, Laurie and Ike Perlmutter contributed $9 million to fund two major joint research endeavors in pursuit of the goal of advancing cancer research. 

The first, a $3 million grant, financed cancer-focused research projects conducted by teams of co-investigators from both NYU Langone and the Technion, Israel Institute of Technology.

The second, a $6 million grant, established a state-of-the-art research facility on Technion's campus in Israel, will support these and other research projects, focusing on the emerging field of cancer metabolomics. 

Dafna Bar-Sagi, PhD, senior vice president and vice dean for science at NYU Langone, chief science officer at NYU School of Medicine, and a principal architect of the NYU Langone-Technion partnership said, "NYU Langone and the Technion have a shared, longstanding commitment to advancing cancer research. We are now at a great moment in our institutions' illustrious histories, a point from which we can jointly leverage the talent and creativity of our researchers towards accelerating breakthroughs. The foresight and generosity of the Perlmutters, particularly at this time of financial challenge in funding for basic research, will have tremendous impact."